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Despite recent advances in the genetics of West Nile (WN) virus, relatively little is known about the molecular basis of
virulence of this virus. In particular, although the genotype of the WN virus strain that was recently introduced into North
America has been determined, there have been few experimental studies on the virulence phenotype of the virus. We
compared genetic and neurovirulence properties of 19 strains of WN virus, including 2 from North America, and observed
significant differences in their neuroinvasive phenotype in mice and hamsters that correlated with virus genotype. VirusINTRODUCTION
West Nile (WN) virus is a member of the Japanese
encephalitis (JE) serocomplex of the Flavivirus genus,
which also includes Alfuy, Koutango, Murray Valley en-
cephalitis (MVE), St. Louis encephalitis (SLE), and JE
viruses (Poidinger et al., 1996). Human infections with
WN virus generally result in a mild undifferentiated fever
that may resemble dengue-like illness and resolves in 3
to 6 days (Monath and Heinz, 1996). However, recent
outbreaks of WN infection in North America, Eastern
Europe, and Israel have been characterized by relatively
high rates of potentially fatal neurological disorders, of-
ten in the elderly (Tsai et al., 1998; Lanciotti et al., 1999;
Novello, 2000; Chowers et al., 2001; Nash et al., 2001;
Platonov et al., 2001). Also, cases of hepatitis resembling
yellow fever have been described in central Africa
(Georges et al., 1988).
Early comparisons of WN virus strains using poly-
clonal sera and monoclonal antibodies in hemagglutina-
tion inhibition and neutralization tests defined at least
three distinct antigenic complexes that were clustered
geographically: a group of primarily Middle Eastern and
European strains; Indian strains; and southern African
strains (Hammam et al., 1965; Price and O’Leary, 1967;
Blackburn et al., 1987; Morvan et al., 1990). Cross-neu-
tralization tests with Kunjin (KUN) virus, isolated in Aus-
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Pathology and WHO Collaborating Center for
Tropical Diseases, The University of Texas Medical Branch, 301 Uni-17tralia, suggested that WN and KUN viruses were closely
related (Doherty et al., 1963; Calisher et al., 1989).
More recently, molecular phylogenetic techniques
have allowed the definition of genotypes of WN virus
strains that approximate the serologically defined anti-
genic groups (Jia et al., 1999; Lanciotti et al., 1999; Scher-
ret et al., 2001). WN virus has been grouped into two
major lineages with several subtypes. Lineage I com-
prises a large group of primarily Middle Eastern, Euro-
pean, and some African isolates. Viruses in this lineage
have been associated with recent outbreaks of human
encephalitis in North America and Eastern Europe. KUN
virus has recently been reclassified as a subtype of WN
virus (Heinz et al., 2000) and groups with the lineage I
viruses. A group of Indian strains of WN virus has also
been associated with lineage I. Lineage II consists of
strains of WN virus isolated in Africa.
Intraperitoneal (ip) injection of WN virus into mice
generally leads to a fatal encephalitis which has been
proposed as a useful model for human encephalitic dis-
ease, although the severity of disease can be dependent
upon the age and strain of mice (Weiner et al., 1970;
Umrigar and Pavri, 1977). Neurovirulence of WN virus in
laboratory mice has also been reported to show some
virus strain-to-strain variation (Umrigar and Pavri, 1977;
Odelola and Fabiyi, 1977).
The recent introduction of WN virus into the Western
hemisphere has drawn attention to WN virus as a public
health problem. However, most recent studies on WN
virus have focused on the molecular biology of the virus,
while knowledge of the virulence of the virus is veryisolated in North America was found to be highly neuroin
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determine whether neurovirulence differences exist be-
tween these viruses that can be correlated with geno-
type.
RESULTS
A total of 17 WN and 2 KUN virus strains were studied
(Table 1). These included strains isolated between 1950
and 1999 from various hosts (bird, human, monkey, mos-
quito, bat, and tick) and geographical locations (Africa,
India, Europe, North America, and Australia).
Nucleotide sequencing and phylogenetic analysis
RT/PCR amplification and nucleotide sequencing of
fragments of envelope (E) protein gene and NS5 protein
gene/3-noncoding region (NCR) were performed using
primer pairs WN132/WN240 (Berthet et al., 1997) and
vd8/emf1 (Pierre et al., 1994), respectively.
Phylogenetic analyses using NS5/3-NCR sequences
(GenBank Accession Nos. AF458343 to AF458361) con-
firmed that these viruses represented WN lineages I and
II, as well as the KUN (associated with lineage I) and
Indian WN groups (Fig. 1). Bootstrap support for the
distinction of lineages I and II was strong, as was the
association of strains of KUN virus within lineage I.
Indian strains of WN virus were less strongly associated
with lineage I (bootstrap values50) and, in some cases
where gap creation and extension penalties for se-
quence alignments were varied, were grouped sepa-
rately (data not shown). These results were consistent
with previous phylogenetic studies (Jia et al., 1999; Lan-
ciotti et al., 1999; Scherret et al., 2001). However, strain
H442 (SA58), which has previously been reported to
group with lineage I viruses (Lanciotti et al., 1999),
grouped with other African lineage II strains (Fig. 1).
Subsequent sequencing of an E protein gene fragment
(GenBank Accession No. AF459403) equivalent to that
analyzed by Lanciotti et al. (GenBank Accession No.
AF205880) confirmed this discrepancy.
E protein glycosylation motif
Envelope protein gene fragment sequences were
used to determine the presence or absence of a putative
E protein glycosylation site (Asn-Tyr-Ser) at residues
E154–156 (Table 1). Most virus strains in lineages I and II
contained this motif; however, it was mutated in several
strains of both lineages: either Asn1543 Ser (e.g., CYP68,
ETH76) or Ser156 3 Pro/Ala (e.g., CAR67, EGY50). As has
been reported previously (Berthet et al., 1997) a 12-
nucleotide deletion was observed in the E protein gene
of SEN90, which results in the deletion of amino acid
residues E154–157.
Variation in neuroinvasiveness between WN virus
genotypes in mice and hamsters
Significant variation was observed in the neuroinva-
siveness of WN and KUN virus strains following ip inoc-
TABLE 1
Characteristics of West Nile and Kunjin Virus Strains Used in This Study
Designation Strain Origin Year Source Lineagea CHOb Passagec
CAR67 ArB-310/67 Central African Republic 1967 Mosquito I S SM10, V1
NIG65 IbAn7019 Nigeria 1965 Bird I  SM4
SEN79 AnD-27875 Senegal 1979 Monkey I  SM3, V1
USA99a 31A United States 1999 Bird I  V3
USA99b 385-99 United States 1999 Bird I  V1
IND68 68856 India 1968 Bat I  SM8, V2
EGY50 Egypt101 Egypt 1950 Human I S SM13, V1
ETH76 EthAn4766 Ethiopia 1976 Bird I N ?; SM1
AUS60 MRM16 (Kunjin) Australia 1960 Mosquito I S SM4
AUS91 K6453 (Kunjin) Australia 1991 Mosquito I  V1
IND57 IG-15578 India 1957 Mosquito WN-India S SM14
IND80 804994 India 1980 Human WN-India S SM11, V1
SEN90 ArD-76104 Senegal 1990 Mosquito II  SM3, V1
CAR82 ArB3573/82 Central African Republic 1982 Tick II  SM4, V1
SA58 SAH-442 South Africa 1958 Human II  SM4, V1
SA89 SPU116-89 South Africa 1989 Human II  SM2, V1
MAD88 ArMg-979 Madagascar 1988 Mosquito II  SM4, V1
CYP68 Q3574-5 Cyprus 1968 Bird II N SM2
MAD78 DakAnMg798 Madagascar 1978 Bird II S ?; V1
a Based on phylogenetic analyses using 3 noncoding region sequences; see Fig. 1.
b Indicates presence or absence of potential N-linked glycosylation site in the E protein sequence (E154–156 NYS): , present; , absent; N,
asparagine mutant (N 3 S); S, serine mutant (S 3 P or S 3 A); , deletion mutant.
c SM, suckling mouse brain; V, Vero cell; ? indicates passage history prior to addition to Reference Collection not defined.
18 BEASLEY ET AL.
ulation of female 3- to 4-week-old NIH Swiss outbred
mice (Table 2). Most lineage I viruses, including those
from the New York outbreak, and some from lineage II
(CAR82, SA58, SA89) were highly virulent [LD50 values
between 0.2 and 50 plaque-forming units (PFU)]. In con-
trast, both KUN viruses examined (AUS60 and AUS91)
and the lineage II virus MAD78 caused neither clinical
signs of illness nor death in mice when inoculated at any
dose up to 10,000 PFU. Several strains of both lineages
caused only sporadic deaths such that LD50 values could
not be reliably determined and these were classified
as poorly neuroinvasive. If LD50 values were calculated
for these viruses, they were all 50 PFU, at least
10-fold higher than those of highly neuroinvasive
strains (Table 2).
For those viruses that caused a lethal infection in
mice, average survival times were similar for most and
ranged between 7 and 9 days (Table 2). The exceptions
were Indian strains IND57 and IND80, which were not
consistently neuroinvasive, but the average survival time
for animals which died was 15.3 0.6 days (3 mice died)
for IND57 and 12.2  2.8 days (11 mice) for IND80. The
neuroinvasive USA99b strain was also inoculated ip into
groups of 7- to 8- and 15- to 16-week-old mice (0.1–100
PFU per animal) to investigate possible age-dependent
susceptibility to infection. The approximate LD50 and av-
erage survival time were comparable to those observed
in 3- to 4-week-old mice: 0.3 PFU and 8.6  1.7 days (at
a dose of 100 PFU) for 7- to 8-week-old mice; 0.5 PFU and
10.1  2.0 days for 15- to 16-week-old mice.
Based on the results of mouse experiments, groups of
five 3- to 4-week-old Golden Syrian hamsters were inoc-
ulated ip with 10,000 PFU of representative neuroinva-
sive (SA58, SEN79, USA99b) and nonneuroinvasive
(CYP68, MAD78, IND80) WN virus strains to determine
whether similar results could be obtained in a different
animal model. Strains SA58, SEN79, and USA99b caused
universal mortality with average survival times of 8.2 
1.1, 9.2 0.4, and 8.8 0.8 days, respectively. In contrast,
TABLE 2
Mouse Neuroinvasiveness and Neurovirulence of WN Virus Strains
Virus
Intraperitoneal inoculation Intracerebral inoculation
LD50
(PFU)
Average survival
time  SD (days)a
LD50
(PFU)
Average survival
time  SD (days)a
Lineage I
CAR67 12.6 8.6 1.5 n.d. n.d.
NIG65 3.2 8.0 0.7 n.d. n.d.
SEN79 0.2 8.0 1.0 0.5 6.4  0.9
USA99a 0.5 8.0 1.2 n.d. n.d.
USA99b 0.5 9.2 2.2 0.1 6.2  0.4
IND68 3.2 8.2 0.8 n.d. n.d.
EGY50 50b 7.7 0.6 0.7 5.2  0.4
ETH76 2000b n/a n.d. n.d.
AUS60 10,000 n/a n.d. n.d.
AUS91 10,000 n/a 3.2 7.8  1.3
IND57 8000b n/a n.d. n.d.
IND80 50b n/a n.d. n.d.
Lineage II
SEN90 50b 8.5 0.7 1.5 5.4  1.5
CAR82 0.8 8.4 1.1 n.d. n.d.
SA58 3.2 7.8 0.8 0.3 7.0  0.0
SA89 5.0 8.8 1.9 0.3 6.2  0.4
MAD88 500b n/a n.d. n.d.
CYP68 10,000 n/a 0.5 5.2  2.7
MAD78 10,000 n/a n.d. n.d.
Note. n.d., not determined.
a For a dose of 103 PFU of virus; only strains which caused mortality
in at least 4 of 5 animals at this dose have average survival time (AST)
values listed. AST at other doses was similar for each strain.
b LD50 values could not be reliably calculated for these virus strains
due to inconsistent mortality across the range of challenge doses.
FIG. 1. Neighbor-joining tree compiled using an 500-bp fragment
covering the NS5/3-NCR junction of WN and KUN viruses (see Table 1
for virus abbreviations). Sequence alignments were prepared using
AlignX/VectorNTI software (Informax Inc.) and phylogenetic analysis
was done with PAUP (version 4.04b2). Homologous JE virus (strain
SA-14) sequence was to root the tree. Numbers indicate bootstrap
values in support of branches to the right (1000 replicates). Underlining
indicates those virus strains classified as neuroinvasive in the mouse
model (ip LD50 values 50 PFU).
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the nonneuroinvasive strains CYP68 and MAD78 caused
no morbidity or mortality in hamsters at the same dose.
Strain IND80, which caused sporadic deaths in mice at
several dilutions, killed one of the five hamsters with
death occurring at day 12 postinoculation.
Neurovirulence of WN and KUN viruses in mice
Neurovirulence of seven representative strains was
examined by intracerebral (ic) inoculation of female 3- to
4-week-old NIH Swiss mice (Table 2). As expected, the
average survival times of mice (5 to 7 days) were re-
duced compared to those following ip inoculation. Both
neuroinvasive and nonneuroinvasive strains were highly
virulent with all LD50 values less than 5 PFU. For most
neuroinvasive strains, the lethal doses differed by 10-fold
or less by the two routes, indicating that these strains are
highly virulent in the mouse neuroinvasiveness model
(Table 2).
Neuroinvasion following intranasal (i.n.) inoculation
Groups of 3- to 4-week-old female NIH Swiss mice
were inoculated i.n. with doses of 1–10,000 PFU of rep-
resentative neuroinvasive and noninvasive WN virus
strains with varying mouse passage histories (Table 3).
Although all strains tested caused some mortality at
higher doses, those strains with longer mouse passage
histories—EGY50 (13 passages) and CAR67 (10 pas-
sages)—seemed to be more virulent via this route, as
determined by shorter average survival times. The non-
neuroinvasive strain CYP68 had the highest LD50 value
(800 PFU). Neuroinvasive strains (USA99b, SA58,
CAR67, and EGY50) had i.n. LD50 values ranging between
200 and 500 PFU.
DISCUSSION
The results of this study demonstrate for the first time
that significant biological differences exist between ge-
netic lineages of WN virus. KUN and Indian WN viruses,
as well as less evolved viruses of lineage II (MAD78,
MAD88, and CYP68), were found to be nonneuroinvasive
or highly attenuated in mice. Overall, on the basis of the
19 strains of WN and KUN viruses examined here, we
have identified groups of related viruses in each of lin-
eages I and II that have distinctly different neuroinvasive
potentials in our mouse model. Interestingly, the neuro-
invasive clades branch more distantly from the root of
the tree (and presumably, from the WN ancestor) than the
noninvasive and attenuated strains (Fig. 1). Differences
in neuroinvasive phenotype were not associated with the
source (mosquito, mammal, bird) or passage history of
virus strains.
Two Indian strains (IND57 and IND80) which were
loosely related to lineage I strains in our phylogenetic
analysis differed from each other and the other strains in
their observed neuroinvasive phenotype: although nei-
ther was highly neuroinvasive, the calculated ip LD50 of
IND80 was much lower than that of IND57 (Table 2); mice
killed by either strain had much longer average survival
times than was observed with neuroinvasive lineage I
and II strains. As stated in the Introduction, serological
comparisons of WN strains have suggested that an In-
dian serotype could be distinguished from Middle East-
ern/European or African serotypes (which would corre-
spond to genotypes I and II as defined by Lanciotti et al.,
1999). The observed genetic distance between these
strains and the other WN genotypes and differences in
neuroinvasive phenotype described in this study suggest
that these viruses may represent a distinct WN subtype.
Clearly, further studies on the Indian WN viruses are
warranted.
Although recent outbreaks of WN encephalitis have
generally been associated with lineage I strains (Tsai et
al., 1998; Lanciotti et al., 1999; Novello, 2000; Chowers et
al., 2001; Nash et al., 2001; Platonov et al., 2001) we have
found strains in both lineages I and II which have a
strong mouse neuroinvasive phenotype. Encephalitis
and other neurological signs associated with WN virus
infection in humans have been reported in India, Africa,
and the Middle East and, unlike the epidemics in North
America and Europe, have tended to involve children and
younger adults (Pruzanski and Altman, 1962; Flatau et al.,
1981; George et al., 1984, 1987; Nur et al., 1999). In many
of these endemic areas WN virus infection is generally a
mild childhood disease and serological surveys have
shown that most of the adult populations are WN im-
mune (Taylor et al., 1956; Tomori et al., 1978)—a very
different epidemiological picture from that in the United
States in 1999 and the following years. Tomori et al.
(1978) also suggested that the widespread presence of
antibodies to other flaviviruses might also play a role in
determining the clinical presentation of WN virus infec-
tion in Africa. Therefore, in addition to virus strain viru-
lence differences, it is probable that host factors such as
age, immune status, and general health may combine to
influence the outcome of WN virus infection in humans.
The observed variation in WN virus strain virulence
makes for interesting comparison with similar studies of
TABLE 3
Effect of Suckling Mouse Brain (SMB) Passage History on Viru-
lence of Selected WN Virus Strains in 3- to 4-Week-Old Female NIH
Swiss Mice Following Intranasal Inoculation
Virus SMB passage LD50 (PFU) AST  SD (days)
a
USA99b 0 200 8.0 1.0
CYP68 2 795 9.0 0.8
SA58 4 315 8.0 0.0
CAR67 10 500 5.8 0.4
EGY50 13 200 6.0 0.0
a For a 10,000-PFU dose of virus.
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virulence phenotypes of strains of SLE virus, another
member of the JE serocomplex and a virus enzootic in
North America (Monath et al., 1980, 1983; Trent et al.,
1981). The above authors also described a range of
virulence phenotypes (neuroinvasive, intermediate and
noninvasive) that were independent of passage history.
Rather, virulence differences correlated with virus geno-
type and were conserved in mouse and hamster models.
Detailed analysis of the pathology associated with
SLE virus neuroinvasion in hamsters determined that,
following peripheral inoculation, entry of virus into the
brain was via the olfactory nerve (Monath et al., 1983).
Similarly, neuroinvasion by MVE virus has been reported
to occur via the olfactory nerve (McMinn et al., 1996).
Although there are reports of i.n. inoculation with WN
virus leading to encephalitis in mice and hamsters (Nir,
1959; Nir et al., 1965; Goverdhan et al., 1992) we have
found that, unlike neuroinvasion following ip inoculation,
this was an inefficient process and the phenotype was
influenced by mouse passage history of the virus strains
tested (Table 3). These results suggest that neuroinva-
sion via the olfactory nerve is not the primary means of
WN virus entry to the brain in this model of WN enceph-
alitis. Consistent with this observation, Xiao et al. (2001)
have reported that WN virus antigen could be detected in
the basal ganglia, brain stem, cerebellar cortex, and gray
matter but not within the olfactory bulb of hamsters
inoculated ip with the USA99b strain.
The similarity of ic and ip LD50 values for neuroinvasive
strains (Table 2; approximately 10-fold differences only)
suggests that these viruses are highly neuroinvasive in
the mouse model. This high level of neuroinvasion is
unusual for many mosquito-borne flaviviruses. For exam-
ple, strains of JE virus (a related virus in the JE serocom-
plex of the Flavivirus genus) exhibit a 10,000-fold differ-
ence between ic and ip LD50 values (Ni and Barrett, 1995,
1998). However, these results are comparable to those
reported for SLE virus (Monath et al., 1980). The high
neuroinvasive potential of WN virus may have some
relevance to the pathogenesis of encephalitic disease
associated with recent outbreaks of human WN virus
infection.
Furthermore, mosquito-borne flaviviruses normally
demonstrate an age-related resistance to infection in
mice [e.g., yellow fever virus (Fitzgeorge and Bradish,
1980)]. The highly neuroinvasive phenotype observed
with the USA99b strain in 15- to 16-week-old mice is
unusual and is also in contrast to results of a previous
study examining experimental WN encephalitis in mice,
which reported that ip inoculation of the Egypt101 strain
(EGY50) into MBR/ICR albino Swiss mice rarely resulted
in fatal illness in mice older than 7 weeks (Weiner et al.,
1970).
Previous comparisons of glycosylated and nonglyco-
sylated variants of an Israeli WN virus strain showed that
either state could be associated with a neuroinvasive or
an attenuated phenotype (Halevy et al., 1994; Chambers
et al., 1998) and recent studies with glycosylated and
nonglycosylated viruses derived from a KUN virus infec-
tious clone indicated that glycosylation of the E protein
was associated with an increased rate of replication in
vitro and higher viremias in mice (J. Scherret, personal
communication). In our study no strong association be-
tween the presence or absence of a potential glycosyl-
ation site and mouse neuroinvasive phenotype was ob-
served. However, two neuroinvasive strains that lacked a
potential glycosylation site (EGY50 and SEN90) had ip
LD50 values approximately 10-fold higher than related
neuroinvasive strains which encoded the glycosylation
motif. More detailed studies are needed to investigate
the extent to which glycosylation might contribute to
variations in WN virus virulence.
The strong neuroinvasive phenotype of WN virus
strains isolated in North America, and closely related
viruses of lineage I, is interesting in light of the relatively
high rate of human encephalitis cases associated with
infections with some viruses in this lineage. Based on
the results of this study, more detailed nucleotide se-
quencing and functional comparisons of neuroinvasive
and attenuated WN virus strains, including the use of WN
infectious clones, should allow the elucidation of the
molecular mechanisms of WN virus virulence.
MATERIALS AND METHODS
Virus propagation
Viruses were obtained from the World Arbovirus Ref-
erence Collection and stocks were grown and plaque
titrated in Vero cells. All viruses were obtained as lyoph-
ilized stocks and passaged once in Vero cells to prepare
working stocks for the experiments described here.
Nucleotide sequencing and phylogenetic analysis
Viral RNA was extracted from the supernatant of WN
or KUN virus-infected Vero cell cultures using a phenol:
chloroform procedure described previously (Ni and Bar-
rett, 1995). RNA was reverse-transcribed using RAV-II
reverse transcriptase (Amersham Pharmacia Biotech
Inc., Piscataway, NJ) and fragments of the NS5 gene/3
noncoding region and E protein gene were PCR ampli-
fied using primer pairs vd8/emf1 (Pierre et al., 1994), and
WN132/WN240 (Berthet et al., 1997), respectively. PCR
products of the appropriate sizes were gel purified using
a QIAquick kit (Qiagen Inc., Chatsworth, CA) according to
the manufacturer’s protocol. Purified DNA was either
directly sequenced in both directions or cloned into the
pGEM-T(Easy) vector (Promega Corp., Madison, WI). For
cloned DNA, multiple clones were analyzed to generate
a consensus sequence.
Assembly of consensus sequences and nucleotide
sequence alignments were performed using programs in
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the Vector NTI Suite software package (Informax Inc.,
Bethesda, MD). Phylogenetic analyses on aligned se-
quences were performed using PAUP (version 4.0b4a)
with both maximum-parsimony analysis and maximum-
likelihood distance parameters (Kimura 2-parameter).
Homologous JE virus (strain SA-14) sequence was used
to root the trees. Bootstrap analysis with 500–1000 rep-
licates was used to determine the robustness of the
groupings.
Mouse and hamster neurovirulence experiments
Groups of five 3- to 4-week-old female NIH Swiss mice
were inoculated ip, ic, or i.n. with 10-fold dilutions of WN
or KUN virus ranging from 0.1 to 10,000 PFU per mouse
(100-l volumes for ip injections; 20 l for ic and i.n.). All
dilutions were performed in sterile phosphate-buffered
saline.
For comparison with results in the mouse model,
groups of five 3- to 4-week-old Golden Syrian hamsters
were inoculated ip with 10,000 PFU (100 l) of represen-
tative neuroinvasive (SA58, SEN79) and nonneuroinva-
sive (CYP68, MAD78, IND80) WN strains.
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